

HY-174367 · 5 mg
MedChemExpress · Cat: HY-174367
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/runx1-eto-in-1.html
Description
RUNX1/ETO-IN-1 is a RUNX1-ETO oncogenic fusion protein inhibitor that specifically targets the NHR2 oligomerization domain. RUNX1/ETO-IN-1 directly interacts with the NHR2 KD,app = 39 ?M . RUNX1/ETO-IN-1 exhibits anti-leukemic activity by inducing apoptosis and promoting differentiation in RUNX1/ETO-translocated AML cells. RUNX1/ETO-IN-1 remains essentially uncharged at physiological pH, demonstrating superior membrane permeability.







